Early research (Phase 1)WithdrawnNCT05176691What this trial is testingHMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHLWho this might be right forCLL/SLLNHLMCL+6 more Hutchmed
Early research (Phase 1)Study completedNCT00098891What this trial is testingMS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or LymphomasWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+41 more National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00002980What this trial is testingDecitabine in Treating Patients With Melanoma or Other Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more California Cancer Consortium
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more City of Hope Medical Center 260
Early research (Phase 1)Study completedNCT00068315What this trial is testingBortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueHematopoietic/Lymphoid CancerNodal Marginal Zone B-cell Lymphoma+9 more National Cancer Institute (NCI) 18
Early research (Phase 1)Ended earlyNCT01744912What this trial is testingUblituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid MalignanciesWho this might be right forNon-Hodgkins LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma+4 more TG Therapeutics, Inc. 10
Early research (Phase 1)Ended earlyNCT00004239What this trial is testing506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver ImpairmentWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Alliance for Clinical Trials in Oncology 10
Testing effectiveness (Phase 2)Study completedNCT00078858What this trial is testingMycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Ended earlyNCT00089076What this trial is testingMDX-010 in Treating Patients With Recurrent or Refractory LymphomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaCutaneous B-cell Non-Hodgkin Lymphoma+20 more National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT00293345What this trial is testing3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+56 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT02981745What this trial is testingStudy of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's MacroglobulinemiaWho this might be right forRelapsed or Refractory B Cell Non-Hodgkin LymphomaChronic Lymphocytic LeukemiaWaldenstrom's Macroglobulinemia+3 more Centaurus Biopharma Co., Ltd. 200
Testing effectiveness (Phase 2)Study completedNCT00436618What this trial is testingEverolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous TreatmentWho this might be right forLeukemiaLymphomaLymphoproliferative Disorder Mayo Clinic 277
Testing effectiveness (Phase 2)Ended earlyNCT01796470What this trial is testingEntospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic MalignanciesWho this might be right forChronic Lymphocytic LeukemiaMantle Cell LymphomaDiffuse Large B-cell Lymphoma+1 more Gilead Sciences 66
Early research (Phase 1)Study completedNCT02242045What this trial is testingStudy to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic LeukemiaIndolent Non-Hodgkin LymphomaFollicular Lymphoma+3 more Gilead Sciences 6
Not applicableStudy completedNCT04391946What this trial is testingObservatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19Who this might be right forChronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease French Innovative Leukemia Organisation 162
Testing effectiveness (Phase 2)Study completedNCT00003658What this trial is testingPentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell CancersWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT00075478What this trial is testingTotal-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionAggressive Non-Hodgkin Lymphoma+10 more Fred Hutchinson Cancer Center 87
Early research (Phase 1)Study completedNCT00621452What this trial is testingGenetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin LymphomaWho this might be right forB-cell Chronic Lymphocytic LeukemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+8 more Fred Hutchinson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT02933320What this trial is testingBI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or LeukaemiaWho this might be right forB-cell LymphomaChronic Lymphocytic LeukaemiaWaldenström Macroglobulinemia Cancer Research UK 14
Early research (Phase 1)Study completedNCT01129193What this trial is testingAR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more Amir Mortazavi 44